You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression

 

Online download statistics by month:

Online download statistics by month: March 2022 to February 2026

AbstractFullPdf
Mar 20229321006470
Apr 2022238260172
May 2022242247119
Jun 202221121864
Jul 202220821356
Aug 202221421846
Sep 202219120263
Oct 202218719970
Nov 202211811947
Dec 202215716142
Jan 202311711854
Feb 202314114170
Mar 202312212394
Apr 2023828358
May 2023636426
Jun 2023616131
Jul 2023868655
Aug 2023989858
Sep 202313813831
Oct 202321522126
Nov 202339139638
Dec 2023747641
Jan 2024525231
Feb 2024414125
Mar 2024606064
Apr 2024757855
May 2024747649
Jun 2024676831
Jul 2024646842
Aug 2024454472
Sep 2024707043
Oct 2024555536
Nov 2024626337
Dec 2024646529
Jan 2025616134
Feb 202520320347
Mar 2025797948
Apr 2025797938
May 2025414130
Jun 2025323315
Jul 2025110
Feb 2026110
Total551256862457